deferoxamine has been researched along with Dermatoses in 22 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The purpose of the present work is to investigate the ability of desferrioxamine (DF) as an iron chelator to revert or decrease a severe experimental porphyria induced by hexachlorobenzene (HCB) in rats; DF treatment started after 17 weeks of HCB intoxication and was continued until the 27th week." | 7.67 | [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene]. ( Aldonatti, CA; Billi, SC; San Martín de Viale, LC; Wainstok de Calmanovici, R, 1987) |
| "The present work deals with the effect of desferrioxamine (DF) on hexachlorobenzene (HCB)-induced porphyria in female rats with the purpose of further investigation of the role of iron in the development of this porphyria." | 7.67 | Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria. ( Aldonatti, CA; Billi, SC; San Martín de Viale, LC; Wainstock de Calmanovici, R, 1986) |
| "The purpose of the present work is to investigate the ability of desferrioxamine (DF) as an iron chelator to revert or decrease a severe experimental porphyria induced by hexachlorobenzene (HCB) in rats; DF treatment started after 17 weeks of HCB intoxication and was continued until the 27th week." | 3.67 | [Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene]. ( Aldonatti, CA; Billi, SC; San Martín de Viale, LC; Wainstok de Calmanovici, R, 1987) |
| "The present work deals with the effect of desferrioxamine (DF) on hexachlorobenzene (HCB)-induced porphyria in female rats with the purpose of further investigation of the role of iron in the development of this porphyria." | 3.67 | Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria. ( Aldonatti, CA; Billi, SC; San Martín de Viale, LC; Wainstock de Calmanovici, R, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (68.18) | 18.7374 |
| 1990's | 5 (22.73) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (9.09) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kong, L | 1 |
| Wu, Z | 1 |
| Zhao, H | 1 |
| Cui, H | 1 |
| Shen, J | 1 |
| Chang, J | 1 |
| Li, H | 1 |
| He, Y | 1 |
| Yang, J | 1 |
| Xia, Y | 1 |
| Liu, X | 1 |
| Jiang, S | 1 |
| Xiong, L | 1 |
| Marchesi, L | 1 |
| Di Padova, C | 1 |
| Cainelli, T | 1 |
| Reseghetti, A | 1 |
| Di Padova, F | 1 |
| Rovagnati, P | 1 |
| Cantoni, L | 1 |
| Gibertini, P | 4 |
| Rocchi, E | 6 |
| Cassanelli, M | 6 |
| Pietrangelo, A | 4 |
| Ventura, E | 6 |
| Halliday, JW | 1 |
| Bassett, ML | 1 |
| Piazza, V | 1 |
| Villa, G | 1 |
| Galli, F | 1 |
| Segagni, S | 1 |
| Bovio, G | 1 |
| Poggio, F | 1 |
| Picardi, L | 1 |
| Bianco, L | 1 |
| Salvadeo, A | 1 |
| Barosi, G | 1 |
| Toriyama, T | 1 |
| Kawahara, H | 1 |
| Borghi, A | 3 |
| Paolillo, F | 1 |
| Pradelli, M | 1 |
| Pellizzardi, S | 1 |
| Vezzosi, A | 1 |
| Gallo, E | 1 |
| Baccarani Contri, M | 1 |
| Stockenhuber, F | 1 |
| Kurz, R | 1 |
| Grimm, G | 1 |
| Moser, G | 1 |
| Balcke, P | 1 |
| Muñoz, JJ | 1 |
| Garcia-Cabezas, J | 1 |
| Martinez-Verano, J | 1 |
| Perez-Oteyza, C | 1 |
| Enriquez de Salamanca, R | 2 |
| Wainstok de Calmanovici, R | 1 |
| Billi, SC | 2 |
| Aldonatti, CA | 2 |
| San Martín de Viale, LC | 2 |
| Pantaleoni, M | 1 |
| Jensen, J | 1 |
| Wainstock de Calmanovici, R | 1 |
| Praga, M | 1 |
| Andres, A | 1 |
| Nieto, J | 1 |
| Oliet, A | 1 |
| Perpiña, J | 1 |
| Morales, JM | 1 |
| Gheorghiu, G | 1 |
| Forsea, D | 1 |
| Thivolet, J | 1 |
| Bondet, P | 1 |
| Perrot, H | 1 |
| Moene, Y | 1 |
| Horvat, Z | 1 |
| Bakran, I | 1 |
| Radosević, Z | 1 |
| Duverne, J | 1 |
| Brizard, CP | 1 |
| Mounier, R | 1 |
| Beurey, J | 1 |
| Weber, M | 1 |
| Gurecki, H | 1 |
| Perello, R | 1 |
| Vadot, J | 1 |
1 trial available for deferoxamine and Dermatoses
| Article | Year |
|---|---|
A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
Topics: Adult; Alcoholism; Clinical Trials as Topic; Deferoxamine; Ferritins; Humans; Hydroxychloroquine; Ir | 1984 |
21 other studies available for deferoxamine and Dermatoses
| Article | Year |
|---|---|
Bioactive Injectable Hydrogels Containing Desferrioxamine and Bioglass for Diabetic Wound Healing.
Topics: Ceramics; Deferoxamine; Diabetes Complications; Endothelial Cells; Gene Expression Regulation; Human | 2018 |
Desferrioxamine shows different potentials for enhancing 5-aminolaevulinic acid-based photodynamic therapy in several cutaneous cell lines.
Topics: Aminolevulinic Acid; Cell Death; Cell Line; Deferoxamine; Drug Synergism; Fibroblasts; Humans; Iron | 2010 |
Porphyria cutanea tarda in beta-thalassemia trait carriers.
Topics: Adult; Deferoxamine; Heterozygote; Humans; Liver Diseases; Male; Middle Aged; Porphyrias; Skin Disea | 1984 |
Advances in the treatment of porphyria cutanea tarda. Effectiveness of slow subcutaneous desferrioxamine infusion.
Topics: Adult; Aged; Deferoxamine; Humans; Infusions, Parenteral; Injections, Subcutaneous; Middle Aged; Por | 1984 |
Treatment of iron storage disorders.
Topics: Anemia; Deferoxamine; Hemochromatosis; Humans; Iron; Liver Cirrhosis; Porphyrias; Skin Diseases; Tha | 1980 |
Erythropoietin as treatment of haemodialysis-related porphyria cutanea tarda.
Topics: Aged; Deferoxamine; Erythrocytes; Erythropoietin; Humans; Iron; Male; Porphyrias; Porphyrins; Protop | 1992 |
[Small volume plasma exchange therapy in patients with porphyria cutanea tarda on maintenance hemodialysis].
Topics: Deferoxamine; Erythropoietin; Humans; Kidney Diseases; Male; Middle Aged; Plasma Exchange; Porphyria | 1992 |
Liver iron overload and desferrioxamine treatment of porphyria cutanea tarda.
Topics: Bloodletting; Chromatography, High Pressure Liquid; Chronic Disease; Deferoxamine; Ferritins; Humans | 1991 |
Successful treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
Topics: Deferoxamine; Female; Humans; Middle Aged; Porphyrias; Renal Dialysis; Skin Diseases | 1990 |
Desferrioxamine in the treatment of porphyria cutanea tarda: ineffectiveness of intramuscular administration.
Topics: Adult; Deferoxamine; Humans; Injections, Intramuscular; Male; Middle Aged; Porphyrias; Skin Diseases | 1990 |
[Evaluation of deferoxamine capacity to revert a severe porphyria induced by hexachlorobenzene].
Topics: 5-Aminolevulinate Synthetase; Animals; Carboxy-Lyases; Deferoxamine; Hexachlorobenzene; Liver; Porph | 1987 |
High weekly intravenous doses of desferrioxamine in porphyria cutanea tarda.
Topics: Aged; Deferoxamine; Dose-Response Relationship, Drug; Humans; Infusions, Intravenous; Male; Middle A | 1987 |
Iron removal therapy in porphyria cutanea tarda: phlebotomy versus slow subcutaneous desferrioxamine infusion.
Topics: Adult; Bloodletting; Deferoxamine; Female; Humans; Infusions, Parenteral; Iron; Male; Middle Aged; P | 1986 |
Effect of desferrioxamine on the development of hexachlorobenzene-induced porphyria.
Topics: 5-Aminolevulinate Synthetase; Animals; Body Weight; Carboxy-Lyases; Chlorobenzenes; Deferoxamine; Di | 1986 |
Treatment of hemodialysis-related porphyria cutanea tarda with deferoxamine.
Topics: Adult; Deferoxamine; Humans; Male; Porphyrias; Renal Dialysis; Skin Diseases | 1987 |
Serum ferritin in the assessment of liver iron overload and iron removal therapy in porphyria cutanea tarda.
Topics: Adult; Deferoxamine; Female; Ferritins; Humans; Iron; Liver; Male; Middle Aged; Porphyrias; Skin Dis | 1986 |
[Treatment of cutaneous porphyrias].
Topics: Adrenocorticotropic Hormone; Anabolic Agents; Deferoxamine; Edetic Acid; Humans; Porphyrias; Skin Di | 1968 |
[Treatment of late cutaneous porphyrias with iron chelating agents (EDTA, Desferral)].
Topics: Adult; Deferoxamine; Edetic Acid; Humans; Male; Middle Aged; Porphyrias; Skin Diseases | 1967 |
[Treatment of late cutaneous porphyria by desferal].
Topics: Deferoxamine; Female; Humans; Middle Aged; Porphyrias; Skin Diseases | 1969 |
[Inveterate leg ulcer in a constitutional hemolytic syndrome with dermosiderosis. Cure by desfrrioxamine].
Topics: Adult; Deferoxamine; Humans; Leg Ulcer; Male; Siderosis; Skin Diseases; Thalassemia | 1967 |
[Favorable clinical and biological action of iron chelator in 4 cases of porphyria cutanea tarda. Attempts at interpretation].
Topics: Adult; Aged; Alcoholism; Deferoxamine; Humans; Male; Porphyrias; Siderosis; Skin Diseases | 1968 |